Stable 2019 predicted for pharma despite political and regulatory risk, finds credit agency 13-Dec-2018 By Ben Hargreaves Scope’s report finds biologics likely to be protected from severe biosimilar erosion but sees warning signs for the generics industry.
Hired and retired: Year’s end edition 13-Dec-2018 By Ben Hargreaves As we move closer to the end of the year, companies are assembling their boardrooms ready for the new year.
